Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Comments
Loading...

Shares of Lantheus Holdings, Inc. LNTH fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.

Lantheus Holdings shares dipped 22.5% to $58.93 on Monday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Invivyd, Inc. IVVD shares surged 170% to $4.40 after the company reported positive initial results from ongoing CANOPY Phase 3 pivotal clinical trial investigating VYD222 for the Prevention of COVID-19.
  • Cuentas Inc. CUEN shares climbed 71.6% to $2.37.
  • iCoreConnect Inc. ICCT shares jumped 49.4% to $2.54 after surging over 73% on Friday.
  • ZimVie Inc. ZIMV gained 42.8% to $16.03 after the company disclosed an agreement to sell its spine business to H.I.G. Capital for $375 million.
  • Biomerica, Inc. BMRA climbed 42.4% to $1.41. Biomerica received FDA 510(k) clearance for its Hp Detect Stool Antigen ELISA test, designed to detect the presence of the H. pylori bacteria.
  • Akso Health Group AHG gained 41.6% to $0.8499.
  • Energy Services of America Corporation ESOA surged 35.4% to $4.7399 following FY23 earnings results.
  • LQR House Inc. LQR gained 30.9% to $3.3649.
  • United States Steel Corporation X rose 26.5% to $49.77 after Nippon Steel announced it will acquire the company for $55 per share in an all-cash transaction.
  • Color Star Technology Co., Ltd. ADD climbed 26.5% to $0.50.
  • ZK International Group Co., Ltd. ZKIN rose 22.3% to $1.26.
  • Wheeler Real Estate Investment Trust, Inc. WHLR shares gained 22.2% to $0.2750 after dipping around 24% on Friday.
  • Arcutis Biotherapeutics, Inc. ARQT gained 21.3% to $2.96 after the FDA approved the company's Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older.
  • Cadrenal Therapeutics, Inc. CVKD climbed 20.5% to $0.6143. Noble Capital Markets initiated coverage on Cadrenal Therapeutics with an Outperform rating and announced a price target of $4.
  • Alaunos Therapeutics, Inc. TCRT shares rose 18% to $0.0537 after declining 11% on Friday.
  • Ideal Power Inc. IPWR gained 16.7% to $9.06.
  • NightHawk Biosciences, Inc. NHWK gained 14% to $0.43 as the company announced major milestone with completion of manufacturing run for a premier U.S.-based biopharmaceutical company.
  • James River Group Holdings, Ltd. JRVR gained 12.8% to $9.58.
  • B. Riley Financial, Inc. RILY rose 10.8% to $22.66.
  • Sonoma Pharmaceuticals, Inc. SNOA shares surged 10.4% to $0.16 after falling over 6% on Friday.
  • Ontrak, Inc. OTRK rose 9.6% to $0.45 after falling over 8% on Friday.
  • Cleveland-Cliffs Inc. CLF gained 8.7% to $20.33 after the company issued a statement regarding the proposed acquisition of U.S. Steel by Nippon Steel.
  • Super Micro Computer, Inc. SMCI rose 7.3% to $321.98.

Losers

  • Ebix, Inc. EBIX shares fell 70.6% to $1.45  after the company and certain US affiliates filed for protection under Chapter 11 and reached a stalking horse agreement to sell its North American Life and Annuity assets to Zinnia.
  • Jin Medical International Ltd. ZJYL dipped 52.1% to $13.43.
  • Cara Therapeutics, Inc. CARA declined 51.1% to $0.6010 as the company announced outcome from dose-finding Part A of KIND 1 study evaluating oral difelikefalin for moderate-to-severe pruritus in patients with atopic dermatitis.
  • Checkpoint Therapeutics, Inc. CKPT shares fell 48.5% to $1.7090. The FDA has issued a Complete Response letter to Checkpoint Therapeutics' Cosibelimab Biologic License Application for metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.
  • Structure Therapeutics Inc. GPCR fell 47.1% to $31.27 after the company announced a comprehensive development program update for GSBR-1290.
  • Near Intelligence, Inc. NIR shares fell 43.9% to $0.0331 after dipping 20% on Friday.
  • Minerva Surgical, Inc. UTRS shares fell 38.3% to $1.7375. On Dec. 15, 2023, Minerva Surgical notified the Nasdaq of its intent to file a Form 25 with the SEC on or about Dec. 26, 2023 to effect the voluntary delisting of the company's common stock from Nasdaq.
  • Maison Solutions Inc. MSS shares fell 38% to $1.55 after dipping 83% on Friday.
  • SunPower Corporation SPWR fell 35% to $3.9899 after the company said substantial doubt exists about its ability to continue as a going concern.
  • PureCycle Technologies, Inc. PCT declined 34.3% to $3.2563 after the company issued Ironton
  • operations update.
  • Fortress Biotech, Inc. FBIO fell 22.8% to $2.37.
  • Shengfeng Development Limited SFWL dipped 22.2% to $7.72.
  • Gossamer Bio, Inc. GOSS fell 22.2% to $0.7938.
  • Conduit Pharmaceuticals Inc. CDT declined 21.5% to $5.54.
  • Gaotu Techedu Inc GOTU fell 19.6% to $3.7250.
  • Know Labs, Inc. KNW declined 19% to $0.6788.
  • Maxeon Solar Technologies, Ltd. MAXN fell 19% to $4.9820. Goldman Sachs maintained Maxeon Solar Technologies with a Buy and lowered the price target from $18 to $11.
  • Mirum Pharmaceuticals, Inc. MIRM fell 19% to $28.31 after announcing data from EMBARK Phase 2b study for biliary atresia.
  • Masonite International Corporation DOOR fell 14.8% to $86.88 after the company announced the acquisition of PGT Innovations.
  • Ainos, Inc. AIMD fell 13.5% to $2.87 after jumping 31% on Friday.
  • bluebird bio, Inc. BLUE dipped 11% to $2.91.
  • LG Display Co., Ltd. LPL fell 10.6% to $4.3510.
  • Lufax Holding Ltd LU declined 10% to $3.1950. Lufax Holding announced that it received a letter from the NYSE dated notifying the company that it is below the NYSE's Continued Listing Standards.
  • Northann Corp. NCL shares fell 9.3% to $14.44 after surging 42% on Friday.
  • Chavant Capital Acquisition Corp. CLAY shares fell 9.2% to $9.53 after gaining 5% on Friday.
  • V.F. Corporation VFC fell 7.7% to $18.38. VF Corp said on Dec. 13, it detected unauthorized occurrences on a portion of its IT systems.
  • Sunrun Inc. RUN fell 6.2% to $17.48. Goldman Sachs maintained Sunrun with a Buy and raised the price target from $17 to $20.

 

Now Read This: Ethereum Falls Below $2,200; Celestia, SATS Among Top Losers

Market News and Data brought to you by Benzinga APIs

Posted In: